LONG TERM BENEFIT OF AUTOLOGOUS BONEMARROW – Jorge Tuma
Introducción Center for Interventional Cardiology and Institute of Autologous Stem Cell, Cencor-Inacel Maisonde Santé Clínic, Lima, PERU, 2Centro Cardiovascular San Nicolás, ARGENTINA, 3Instituto deCriopreservación y Terapia Celular, Lima, PERU, 4The University of Utah.
Optimized Mesenchymal Stem Cell Therapy for Chronic Obstructive Pulmonary Disease – Jorge Tuma
Five year follow-up of coronary sinus delivery of bone marrow cells for congestive heart failure
Introducción Background: Randomized studies suggest that intracoronary infusion of autologous cells improve heart function for patients with heart failure (HF). However, results have been mixed due to high cell loss and poor delivery. Coronary sinus delivery (CSD) of bone marrow cells holds promise for patients with HF. Methods: 77 patients were enrolled and completed 5 years follow up. […]
Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina – Jorge Tuma
Introducción Background: Chronic refractory angina is a challenging clinical problem with limited treatment options. The results of early cardiovascular stem cell trials using ABMMC have been promising but have utilized intracoronary or intramyocardial delivery. The goal of the study was to evaluate the safety and early efficacy of autologous bone marrow derived mononuclear cells (ABMMC) delivered […]